Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006492 | 12600649 | 2 | F | 20160501 | 20160803 | 20160727 | 20160808 | EXP | IT-GILEAD-2016-0224725 | GILEAD | 76.00 | YR | E | F | Y | 0.00000 | 20160808 | PH | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126006492 | 12600649 | 1 | PS | HARVONI | LEDIPASVIRSOFOSBUVIR | 1 | Oral | 1 DF, QD | 205834 | 1 | DF | TABLET | QD | ||||||
| 126006492 | 12600649 | 2 | SS | REBETOL | RIBAVIRIN | 1 | Oral | 4 DF, QD | 0 | 4 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126006492 | 12600649 | 1 | Chronic hepatitis C |
| 126006492 | 12600649 | 2 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126006492 | 12600649 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126006492 | 12600649 | Abdominal pain upper | |
| 126006492 | 12600649 | Anaemia | |
| 126006492 | 12600649 | Fatigue | |
| 126006492 | 12600649 | Headache | |
| 126006492 | 12600649 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126006492 | 12600649 | 1 | 20160501 | 0 | ||
| 126006492 | 12600649 | 2 | 20160501 | 0 |